Gail K. Boudreaux is the CEO of Elevance Health, Inc., a position she has held since November 2017. With a strong background in healthcare, she earned her MBA from Columbia Business School and has extensive experience in leading major healthcare...

Gail K. Boudreaux is the CEO of Elevance Health, Inc., a position she has held since November 2017. With a strong background in healthcare, she earned her MBA from Columbia Business School and has extensive experience in leading major healthcare organizations. Before joining Elevance Health, she founded and ran GKB Global Health, a healthcare strategy firm, and held high-level roles at UnitedHealth Group, where she was CEO of UnitedHealthcare and Executive VP. Under her leadership, Elevance Health is focused on performance-based growth, shown by her compensation structure where significant parts are tied to company success. In 2023, her total earnings reached approximately $22 million, highlighting her impact on the company's performance. Boudreaux is also known for her strategic moves in the stock market, with her holdings fluctuating significantly over the years. At one point, her stock worth reached $164.70 million. She believes in aligning executive goals with shareholder interests, which is key to her role. This approach combines solid business thinking with a focus on the future of healthcare.

Quick Links

1. Rivals

2. Holdings

3. Insider Trading

4. Compensation History

5. Other Elevance Health CEOs

E

Gail K. Boudreaux

CEO of Elevance Health

Education

MBA from Columbia Business School.

Field of Expertise

Healthcare & Life Sciences - Healthcare

Sector of Economy

Healthcare

Born

June 1, 1960 - 64 years ago

CEO of Elevance Health for

7 years 4 months (Nov 2017 - Present)

Previous Experience

CEO of GKB Global Health, LLC and Executive Vice President of United HealthGroup.

Rivals

Competitors/colleagues of Gail K. Boudreaux

M

Joseph M. Zubretsky

CEO of Molina Healthcare

2023 Compensation

Stock

$1.15M

Salary

$1.10M

Bonus

$2.04M

Other

$87.75K

Total Holdings

$110.57M

U

Sir Andrew P. Witty

CEO of UnitedHealth Group

2023 Compensation

Stock

$1.00M

Salary

$1.50M

Bonus

$1.80M

Other

$0.00

Total Holdings

$49.01M

C

Sarah M. London

CEO of Centene

2023 Compensation

Stock

$0.00

Salary

$1.40M

Bonus

$2.79M

Other

$285.34K

Total Holdings

$40.36M

Holdings

See how much did Gail K. Boudreaux make over time.

Gail K. Boudreaux has had notable fluctuations in her stock holdings that reflect her commitment to Elevance Health. In September 2019, her holdings were valued at $41.50 million, which gradually rose to about $165 million by February 2024. These variations...

Gail K. Boudreaux has had notable fluctuations in her stock holdings that reflect her commitment to Elevance Health. In September 2019, her holdings were valued at $41.50 million, which gradually rose to about $165 million by February 2024. These variations illustrate her alignment with the company's success. The peak came in December 2023, hitting $164.70 million, before a slight decrease. Throughout her tenure, significant investments and strategic decisions led to a consistent increase in her net worth related to the company shares. This close connection to her companies' performance highlights her strong belief in the healthcare sector's potential for growth.

Jan 24, 2025

E

shares

ELV @ $400.96

U

shares

UNH @ $532.51

X

shares

XEL @ $66.61

Total Stock Sold

$42.46M

UNH

$25.33M

432,768 UNH shares

ELV

$17.13M

34,000 ELV shares

What if they kept their stock?

If Gail K. Boudreaux didn't sell their stock, today they would have:
Extra UNH432,768 shares worth $114.31M and ELV34,000 shares worth $16.09M.
This is 207.09% and $87.93M more than what they got when they sold the stock.

Charitable Transactions

UNH

35,542 shares

UNH

ELV

10,000 shares

ELV

Recent Charitable Transactions

ELV

10,000 shares

ELV

Nov 4, 2022

Charity

UNH

2,771 shares

UNH

Mar 26, 2012

Charity

UNH

32,771 shares

UNH

Feb 5, 2009

Charity

Insider Trading

See recent insider trades of Gail K. Boudreaux.

ELV

26,207 shares

ELV

Mar 3, 2025

Received

ELV

$17.06M

ELV at $501.74/share

Jul 22, 2024

Sale

ELV

42,932 shares

ELV

Mar 1, 2024

Received

ELV

44,297 shares

ELV

Mar 1, 2023

Received

ELV

10,000 shares

ELV

Nov 4, 2022

Charity

UNH

657.185 shares

UNH

Sep 23, 2014

Received

UNH

687.972 shares

UNH

Jun 25, 2014

Received

UNH

519.746 shares

UNH

Mar 25, 2014

Received

UNH

$6.88M

UNH at $76.09/share

Feb 27, 2014

Sale

UNH

$7.76M

UNH at $46.83/share

Feb 12, 2014

Received

Compensation History

See how much did Gail K. Boudreaux make over time.

In 2023, Gail K. Boudreaux's total compensation was approximately $22 million. This package included a $1.6 million salary, a performance-based bonus of nearly $3.6 million, plus $840,000 in other compensation that includes perks like corporate aircraft usage. Her pay emphasizes the company's performance, which is important to aligning her interests with those of shareholders. Over recent years, her earnings reflect not just her leadership but also the company's focus on performance metrics like net income and revenue. Her compensation philosophy ties a substantial amount of her pay to the long-term success of Elevance Health, indicating a strategic approach to leadership.

Year

2023

Total Compensation

$6.09M

Salary

$1.60M

Board Justification

The compensation philosophy emphasizes performance-based compensation, aligning executive interests with shareholder interests through a mix of fixed and variable compensation, with a significant portion tied to long-term performance.

Bonus

$3.65M

Board Justification

Based on Company performance, the awards earned as a percentage of their respective target awards for 2023 were 114% for Ms. Boudreaux.

Other

$840.96K

Board Justification

Includes tax equalization payments, corporate aircraft usage, and other perquisites.

Restricted Stock

$0.00(0 N/A)

Board Justification

No stock grants were vested in 2023 as the focus is on performance-based compensation and long-term incentives.

Performance Metrics

The performance metrics for determining compensation included Adjusted Net Income, Operating Revenue, and various operational performance measures.

Other Elevance Health CEOs

Here are other CEOs of Elevance Health

Joseph R. Swedish

Ex-CEO of Elevance Health

March 2013 - November 2017